BIOFRONTERA INC (BFRI:NASDAQ)
$0.858 0.063 (7.9245%)
Analysed BIOFRONTERA INC (BFRI:NASDAQ) News Sources
Biofrontera Inc (BFRI) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
21-03-2026
yahoo.com
Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss
07-05-2026
yahoo.com
Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026
08-05-2026
yahoo.com
Humacyte, Inc. (HUMA) Reports Q1 Loss, Misses Revenue Estimates
13-05-2026
yahoo.com
Biofrontera Launches Second Annual “Hats On” Campaign to Raise Awareness of Actinic Keratosis
13-05-2026
yahoo.com
Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update
14-05-2026
yahoo.com
Biofrontera Inc. (BFRI) Reports Q1 Loss, Beats Revenue Estimates
14-05-2026
yahoo.com
Biofrontera Inc (BFRI) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...
14-05-2026
yahoo.com
StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls
19-05-2026
yahoo.com
Biofrontera Inc. to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
21-05-2026
yahoo.com
What is the current price of BIOFRONTERA INC (BFRI:NASDAQ)?
The current price of BIOFRONTERA INC (BFRI:NASDAQ) is $0.858.
BIOFRONTERA INC (BFRI:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOFRONTERA INC (BFRI:NASDAQ) since the previous trading day is $0.063.
BIOFRONTERA INC (BFRI:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOFRONTERA INC (BFRI:NASDAQ) since the previous trading day is 7.9245%.
What is the most recent average sentiment score for BIOFRONTERA INC (BFRI:NASDAQ)?
The most recent average sentiment score for BIOFRONTERA INC (BFRI:NASDAQ) is 49 out of 100.
What is the most recent average sentiment for BIOFRONTERA INC (BFRI:NASDAQ)?
The most recent sentiment for BIOFRONTERA INC (BFRI:NASDAQ) is .
SEC-8K** Filing Available For BIOFRONTERA INC (BFRI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.